Qiagen (NYSE: QGEN) reported Q4 EPS of $0.62, in-line with the analyst estimate of $0.62. Revenue for the quarter came in at $540 million versus the consensus estimate of $528.47 million.

2026 outlook: Net sales growth of at least 5% CER with growth pillars expected to contribute about $1.64 billion CER (~+9% CER) and adj. diluted EPS of at least $2.50 CER

For earnings history and earnings-related data on Qiagen (QGEN) click here.